Annotation Detail
Information
- Associated Genes
- IKBKB
- Associated Variants
-
IKBKB MUTATION
IKBKB MUTATION - Associated Disease
- T-Cell Lymphoma
- Source Database
- DisGeNET
- Description
- To evaluate the pharmacologic activity of a novel inhibitor of IκB kinase β (IKK2), LY2409881, in preclinical models of B- and T-cell lymphoma, as a single agent and in combination with histone deacetylase (HDAC) inhibitors.
- Pubmed
- 25355930
- Section of the abstract supporting the evidence
- PURPOSE
- Number of the section of the abstract supporting the evidence
- 1
- Number of the sentence supporting the evidence
- 1
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.000271441872080303
Drugs